Mécanisme action And NotHelmut Drexler
List of bibliographic references
Number of relevant bibliographic references: 30.Ident. | Authors (with country if any) | Title |
---|---|---|
000B81 | César Mattei [France] ; Frédéric Meunier [Australie] | Toxines botuliques: poison et médicament |
000E80 | Delphine B. Maurel [France] ; Stephane Pallu [France] ; Christelle Jaffre [France] ; Nicola L. Fazzalari [France, Australie] ; Nathalie Boisseau [France] ; Rustem Uzbekov [France] ; Claude-Laurent Benhamou [France] ; Gael Y. Rochefort [France] | Osteocyte Apoptosis and Lipid Infiltration as Mechanisms of Alcohol-Induced Bone Loss |
001C76 | MICHELLE HONG [Singapour] ; Anne-Laure Puaux [Singapour] ; Caleb Huang [Singapour] ; Laure Loumagne [Singapour] ; Charlene Tow [Singapour] ; Charles Mackay [Australie] ; Masashi Kato [Japon] ; Armelle Prevost-Blondel [France] ; Marie-Françoise Avril [France] ; Alessandra Nardin [Singapour] ; Jean-Pierre Abastado [Singapour] | Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control |
001E00 | C. Underhill [France, Australie] ; M. Toulmonde [France] ; H. Bonnefoi [France] | A review of PARP inhibitors: from bench to bedside |
002563 | Truong D. Nguyen-Huu [Australie] ; César Mattei [France] ; Peter J. Wen [Australie] ; Andrea J. Bourdelais [États-Unis] ; Richard J. Lewis [Australie] ; Evelyne Benoit [France] ; Daniel G. Baden [États-Unis] ; Jordi Molgo [France] ; Frédéric A. Meunier [Australie] | Ciguatoxin-induced catecholamine secretion in bovine chromaffin cells: Mechanism of action and reversible inhibition by brevenal |
002D99 | Hai-Tao Zhao [Australie] ; Isabelle Hazemann [France] ; Andre Mitschler [France] ; Vincenzo Carbone [Australie] ; Andrzej Joachimiak [États-Unis] ; Steve Ginell [États-Unis] ; Alberto Podjamy [France] ; Ossama El-Kabbani [Australie] | Unusual Binding Mode of the 2S4R Stereoisomer of the Potent Aldose Reductase Cyclic Imide Inhibitor Fidarestat (2S4S) in the 15 K Crystal Structure of the Ternary Complex Refined at 0.78 Å Resolution : Implications for the Inhibition Mechanism |
003293 | E. A. Gould [France, Royaume-Uni] ; T. Solomon [Royaume-Uni] ; J. S. Mackeuzie [Australie] | Does antiviral therapy have a role in the control of Japanese encephalitis? |
004D37 | Jason S. Carroll [Australie] ; Danielle K. Lynch [Australie] ; Alexander Swarbrick [Australie] ; Jack-Michel Renoir [France] ; Boris Sarcevic [Australie] ; Roger J. Daly [Australie] ; Elizabeth A. Musgrove [Australie] ; Robert L. Sutherland [Australie] | p27Kip1 induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells |
004E31 | Ego Seeman [Australie] | Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis |
004E68 | Jean-Marie Boeynaems [Belgique] ; Francoise Wilkin [Belgique] ; Frédéric Marteau [Belgique] ; Xavier Duhant [Belgique] ; Pierre Savi [France] ; Nathalie Suarez Gonzalez [Belgique] ; Bernard Robaye [Belgique] ; Didier Communi [Belgique] | P2Y receptors: New subtypes, new functions |
005258 | Edmond Ekué Creppy [France] ; Adama Traore [France] ; Isabelle Baudrimont [France] ; Marta Cascante [Espagne] ; Maria-Rosaria Carratu [Italie] | Recent advances in the study of epigenetic effects induced by the phycotoxin okadaic acid |
005303 | R. A. Roberts [France] ; S. Chevalier [France] ; S. C. Hasmall [Royaume-Uni] ; N. H. James [Royaume-Uni] ; S. C. Cosulich [Royaume-Uni] ; N. Macdonald [Royaume-Uni] | PPARα and the regulation of cell division and apoptosis |
005444 | Jerome Rossert [France] ; William M. Mcclellan [États-Unis] ; Simon D. Roger [Australie] ; Dierik L. Verbeelen [Belgique] | Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression? |
005552 | Robert E. Widdop [Australie] ; Khalid Matrougui [France] ; Bernard I. Levy [France] ; Daniel Henrion [France] | AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade |
005843 | C. Sonich-Mullin [Suisse] ; R. Fielder [Royaume-Uni] ; J. Wiltse [États-Unis] ; K. Baetcke [États-Unis] ; J. Dempsey [Australie] ; P. Fenner-Crisp [États-Unis] ; D. Grant ; M. Hartley [Australie] ; A. Knaap [Pays-Bas] ; D. Kroese [Pays-Bas] ; I. Mangelsdorf [Allemagne] ; E. Meek [Canada] ; J. M. Rice [France] ; M. Younes [Suisse] | IPCS conceptual framework for evaluating a mode of action for Chemical carcinogenesis |
005C18 | N. J. Russell [Royaume-Uni] ; M. Colley [Royaume-Uni] ; R. K. Simpson [Royaume-Uni] ; A. J. Trivett [Royaume-Uni] ; R. I. Evans [Royaume-Uni] | Mechanism of action of pulsed high electric field (PHEF) on the membranes of food-poisoning bacteria is an 'all-or-nothing' effect |
005C54 | Pascal Bousquet [France] ; Monique Dontenwill [France] ; Hugues Greney [France] ; Josiane Feldman [France] | Imidazoline receptors in cardiovascular and metabolic diseases |
005E20 | A. Lansiaux [France] ; A. Adams [Australie] ; W. A. Denny [Nouvelle-Zélande] ; C. Bailly [France] | Le DACA |
005E48 | V. Gerome [France] ; D. Lapraz [France] ; P. Iacconi [France] ; M. Benabdesselam [France] ; H. Prevost [France] ; A. Baumer [France] | Thermoluminescence mechanisms in rare earth doped CaSO4 |
005E50 | G. Molnar [France, Hongrie] ; E. Papin [France] ; P. Grosseau [France] ; B. Guilhot [France] ; J. Borossay [Hongrie] ; M. Benabdesselam [France] ; P. Iacconi [France] ; D. Lapraz [France] | Thermally stimulated luminescence and exoelectron emission mechanism of the 430 K (D') dosimetric peak of α-Al2O3 |
005E94 | J. I. Fletcher [Australie] ; XIUHONG WANG [Australie] ; M. Connor [Australie] ; M. J. Christie [Australie] ; G. F. King [Australie] ; G. M. Nicholson [Australie] | Spider toxins : A new group of potassium channel modulators |
005F37 | M. Pabon [France] ; J. Selb [France] ; F. Candau [France] ; R. G. Gilbert [Australie] | Polymerization of acrylamide in solution and inverse emulsion : number molecular weight distribution with chain transfer agent |
006005 | P. Brooks [Australie] ; P. Emery [Royaume-Uni] ; J. F. Evans [États-Unis] ; H. Fenner [Suisse] ; C. J. Hawkey [Royaume-Uni] ; C. Patrono [Italie] ; J. Smolen [Autriche] ; F. Breedveld [Pays-Bas] ; R. Day [Australie] ; M. Dougados [France] ; E. W. Ehrich [États-Unis] ; J. Gijon-Banos [Espagne] ; T. K. Kvien [Norvège] ; M. H. Van Rijswijk [Pays-Bas] ; T. Warner [Royaume-Uni] ; H. Zeidler [Allemagne] | Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2 |
006016 | JIN BO SU [France] ; F. Barbe [France] ; B. Crozatier [France] ; D. J. Campbell [Australie] ; L. Hittinger [France] | Increased bradykinin levels accompany the hemodynamic response to acute inhibition of angiotensin-converting enzyme in dogs with heart failure |
006123 | S. Guissi [France] ; P. Iacconi [France] ; R. Bindi [France] ; D. Lapraz [France] | Characterisation and modelling of the 450 K TSL peak of alpha alumina by the simultaneous analysis of TSL, TSC and TSEE |
006710 | S. Aubert [France] ; R. Bligny [France] ; D. A. Day [Australie] ; J. Whelan [Australie] ; R. Douce [France] | Induction of alternative oxidase synthesis by herbicides inhibiting branched-chain amino acid synthesis |
006760 | J. L. Smith [Australie] ; C. Lutton [France] | Determination of hepatic acyl-coenzyme A-cholesterol acyltransferase activity in LPN hamsters : A model for cholesterol gallstone formation |
006965 | L. P. Rivory [Australie] ; M. R. Bowles [Australie] ; J. Robert [France] ; S. M. Pond [Australie] | Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase |
006B14 | G. A. Head [Australie] | Baroreflexes and cardiovascular regulation in hypertension |
006C18 | C. J. Ormandy [Australie] ; C. S. L. Lee [Australie] ; P. A. Kelly [France] ; R. L. Sutherland [Australie] | Regulation of prolactin receptor expression by the tumour promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate in human breast cancer cells |
![]() | This area was generated with Dilib version V0.6.33. | ![]() |